Resultados de la búsqueda 291-300 of 4268 for Relapse

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic ...

  6. Oncología (médica) - Ensayos clínicos

    Additionally, no studies to date have investigated this during intralesional tumor resections. NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or ...

  8. Oncología (médica) - Ensayos clínicos

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients at high risk of relapse are eligible for InPACT-pelvis, where they ... Also, to improve disease control by decreasing the number of spinal relapses ...